Hemangioendothelioma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Conditions: Angiosarcoma; Epithelioid Hemangioendothelioma Intervention: Drug: Eribulin Sponsors: Massachusetts General Hospital; Eisai Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2017 Category: Research Source Type: clinical trials
Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome
Conditions: Kaposiform Hemangioendothelioma; Kasabach Merritt Phenomenon Interventions: Drug: Sirolimus; Drug: Prednisolone Sponsor: West China Hospital Recruiting - verified June 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2017 Category: Research Source Type: clinical trials
